| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP, Research &Investments | EVP &Co-head Of R&I | EVP &Co-head Research &Inv.
1 company
Urist Marshall is an EVP, Research &Investments at Royalty Pharma plc. Recent SEC Form 4 filings include 0 buys and 7 sells.
Estimated insider holdings value: $964K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 24, 2022 | RPRX Royalty Pharma Plc | EVP, Research &Investments | Sell | 23,333 | $43.19 | $1,007,693.94 | -50.0% | -4.5% | -27.7% | |
| May 16, 2022 | RPRX Royalty Pharma Plc | EVP, Research &Investments | Sell | 23,333 | $39.85 | $929,836.38 | -33.3% | +9.6% | -16.3% | |
| Jun 7, 2021 | RPRX Royalty Pharma Plc | EVP &Co-head Of R&I | Sell | 33,134 | $46.08 | $1,526,720.52 | -66.7% | -15.7% | -9.5% | |
| Jun 2, 2021 | RPRX Royalty Pharma Plc | EVP &Co-head Research &Inv. | Sell | 14,566 | $41.52 | $604,850.24 | -30.5% | -9.7% | -3.9% | |
| May 21, 2021 | RPRX Royalty Pharma Plc | EVP &Co-head Research &Inv. | Sell | 2,000 | $41.08 | $82,159.03 | -2.1% | -4.1% | -1.2% |